Skip to main content
PMC home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 2000 Sep;83(2):F109–F111. doi: 10.1136/fn.83.2.F109

Effects of prematurity, intrauterine growth status, and early dexamethasone treatment on postnatal bone mineralisation

S Kurl, K Heinonen, E Lansimies
PMCID: PMC1721150  PMID: 10952703

Abstract

AIM—To examine the hypothesis that, apart from prematurity, intrauterine growth status (expressed as gestational age specific birth weight standard deviation scores), neonatal factors, and duration of dexamethasone treatment influence bone mineralisation in early infancy.
METHODS—In this prospective study, groups consisted of 15 preterm small for gestational age infants (SGA group) and 43 preterm appropriate for gestational age infants (AGA group). A reference group contained 17 term infants. Body size is known to affect bone mineral content (BMC), therefore postnatal bone mineralisation was measured when the study infants and controls had attained a similar body size. Bone mineral density (BMD) and BMC were determined by dual energy x ray absorptiometer of the lumbar spine (L2-L4).
RESULTS—Both preterm groups had significantly lower BMC and BMD than the weight matched term reference group, but no difference was found in BMC and BMD between preterm SGA and AGA infants. In stepwise regression analysis, bone area, duration of dexamethasone treatment, weight at examination, and weight gain per week were the most significant factors, explaining 54% of the variance of the BMC values.
CONCLUSION—In particular, weight at examination, prematurity, and possibly dexamethasone treatment, but not intrauterine growth status, affect postnatal bone mineralisation.


Full Text

The Full Text of this article is available as a PDF (120.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amin S., LaValley M. P., Simms R. W., Felson D. T. The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach. Arthritis Rheum. 1999 Aug;42(8):1740–1751. doi: 10.1002/1529-0131(199908)42:8<1740::AID-ANR25>3.0.CO;2-E. [DOI] [PubMed] [Google Scholar]
  2. Chen J. Y., Ling U. P., Chiang W. L., Liu C. B., Chanlai S. P. Total body bone mineral content in small-for-gestational -age, appropriate-for-gestational -age, large-for-gestational -age term infants and appropriate-for-gestational -age preterm infants. Zhonghua Yi Xue Za Zhi (Taipei) 1995 Aug;56(2):109–114. [PubMed] [Google Scholar]
  3. Chunga Vega F., Gómez de Tejada M. J., González Hachero J., Pérez Cano R., Coronel Rodriguez C. Low bone mineral density in small for gestational age infants: correlation with cord blood zinc concentrations. Arch Dis Child Fetal Neonatal Ed. 1996 Sep;75(2):F126–F129. doi: 10.1136/fn.75.2.f126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Greer F. R., McCormick A. Bone mineral content and growth in very-low-birth-weight premature infants. Does bronchopulmonary dysplasia make a difference? Am J Dis Child. 1987 Feb;141(2):179–183. doi: 10.1001/archpedi.1987.04460020069029. [DOI] [PubMed] [Google Scholar]
  5. Koo W. W., Walters J., Bush A. J., Chesney R. W., Carlson S. E. Dual-energy X-ray absorptiometry studies of bone mineral status in newborn infants. J Bone Miner Res. 1996 Jul;11(7):997–102. doi: 10.1002/jbmr.5650110717. [DOI] [PubMed] [Google Scholar]
  6. Lapillonne A., Braillon P., Claris O., Chatelain P. G., Delmas P. D., Salle B. L. Body composition in appropriate and in small for gestational age infants. Acta Paediatr. 1997 Feb;86(2):196–200. doi: 10.1111/j.1651-2227.1997.tb08868.x. [DOI] [PubMed] [Google Scholar]
  7. Lapillonne A., Guerin S., Braillon P., Claris O., Delmas P. D., Salle B. L. Diabetes during pregnancy does not alter whole body bone mineral content in infants. J Clin Endocrinol Metab. 1997 Dec;82(12):3993–3997. doi: 10.1210/jcem.82.12.4409. [DOI] [PubMed] [Google Scholar]
  8. Minton S. D., Steichen J. J., Tsang R. C. Decreased bone mineral content in small-for-gestational-age infants compared with appropriate-for-gestational-age infants: normal serum 25-hydroxyvitamin D and decreasing parathyroid hormone. Pediatrics. 1983 Mar;71(3):383–388. [PubMed] [Google Scholar]
  9. Namgung R., Tsang R. C., Specker B. L., Sierra R. I., Ho M. L. Reduced serum osteocalcin and 1,25-dihydroxyvitamin D concentrations and low bone mineral content in small for gestational age infants: evidence of decreased bone formation rates. J Pediatr. 1993 Feb;122(2):269–275. doi: 10.1016/s0022-3476(06)80132-0. [DOI] [PubMed] [Google Scholar]
  10. Petersen S., Gotfredsen A., Knudsen F. U. Total body bone mineral in light-for-gestational-age infants and appropriate-for-gestational-age infants. Acta Paediatr Scand. 1989 May;78(3):347–350. doi: 10.1111/j.1651-2227.1989.tb11090.x. [DOI] [PubMed] [Google Scholar]
  11. Pihkala J., Hakala T., Voutilainen P., Raivio K. Uudet suomalaiset sikiön kasvukäyrät. Duodecim. 1989;105(18):1540–1546. [PubMed] [Google Scholar]
  12. Pohlandt F., Mathers N. Bone mineral content of appropriate and light for gestational age preterm and term newborn infants. Acta Paediatr Scand. 1989 Nov;78(6):835–839. doi: 10.1111/j.1651-2227.1989.tb11159.x. [DOI] [PubMed] [Google Scholar]
  13. Rubinacci A., Sirtori P., Moro G., Galli L., Minoli I., Tessari L. Is there an impact of birth weight and early life nutrition on bone mineral content in preterm born infants and children? Acta Paediatr. 1993 Sep;82(9):711–713. doi: 10.1111/j.1651-2227.1993.tb12543.x. [DOI] [PubMed] [Google Scholar]
  14. Ryan S., Congdon P. J., Horsman A., James J. R., Truscott J., Arthur R. Bone mineral content in bronchopulmonary dysplasia. Arch Dis Child. 1987 Sep;62(9):889–894. doi: 10.1136/adc.62.9.889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Saag K. G., Emkey R., Schnitzer T. J., Brown J. P., Hawkins F., Goemaere S., Thamsborg G., Liberman U. A., Delmas P. D., Malice M. P. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med. 1998 Jul 30;339(5):292–299. doi: 10.1056/NEJM199807303390502. [DOI] [PubMed] [Google Scholar]
  16. Seeman E., Wahner H. W., Offord K. P., Kumar R., Johnson W. J., Riggs B. L. Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Invest. 1982 Jun;69(6):1302–1309. doi: 10.1172/JCI110570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Weiler H. A., Paes B., Shah J. K., Atkinson S. A. Longitudinal assessment of growth and bone mineral accretion in prematurely born infants treated for chronic lung disease with dexamethasone. Early Hum Dev. 1997 Feb 20;47(3):271–286. doi: 10.1016/s0378-3782(96)01783-5. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES